Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

Key facts

Sponsor

GOG Foundation

Principal Investigator

Jubilee Brown, MD

NRG Oncology

Intervention

Bleomycin Sulfate(biological)

Enrollment

63 enrolled

Eligibility

18 years · FEMALE

Timeline

2010 – 2022

Study locations (30)

• Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States
• Alaska Women's Cancer Care, Anchorage, Alaska, United States
• Anchorage Oncology Centre, Anchorage, Alaska, United States
• Katmai Oncology Group, Anchorage, Alaska, United States
• Providence Alaska Medical Center, Anchorage, Alaska, United States
• Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States
• Olive View-University of California Los Angeles Medical Center, Sylmar, California, United States
• University of Colorado Hospital, Aurora, Colorado, United States
• Hartford Hospital, Hartford, Connecticut, United States
• The Hospital of Central Connecticut, New Britain, Connecticut, United States
• Sibley Memorial Hospital, Washington D.C., District of Columbia, United States
• Northside Hospital, Atlanta, Georgia, United States
• Augusta University Medical Center, Augusta, Georgia, United States
• Northside Hospital-Forsyth, Cumming, Georgia, United States
• Central Georgia Gynecologic Oncology, Macon, Georgia, United States
• +15 more locations on ClinicalTrials.gov

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.